PETX
Principal Financial Group’s Aratana Therapeutics, Inc. PETX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-19,343
| Closed | -$100K | – | 2294 |
|
2019
Q2 | $100K | Buy |
+19,343
| New | +$100K | ﹤0.01% | 2182 |
|
2019
Q1 | – | Sell |
-335,400
| Closed | -$2.06M | – | 2263 |
|
2018
Q4 | $2.06M | Sell |
335,400
-10,525
| -3% | -$64.5K | ﹤0.01% | 1711 |
|
2018
Q3 | $2.02M | Sell |
345,925
-9,475
| -3% | -$55.3K | ﹤0.01% | 1758 |
|
2018
Q2 | $1.51M | Buy |
355,400
+66,400
| +23% | +$282K | ﹤0.01% | 1783 |
|
2018
Q1 | $1.27M | Sell |
289,000
-1,900
| -0.7% | -$8.38K | ﹤0.01% | 1794 |
|
2017
Q4 | $1.53M | Sell |
290,900
-103,685
| -26% | -$545K | ﹤0.01% | 1790 |
|
2017
Q3 | $2.42M | Buy |
394,585
+3,200
| +0.8% | +$19.6K | ﹤0.01% | 1708 |
|
2017
Q2 | $2.83M | Buy |
391,385
+124
| +0% | +$897 | ﹤0.01% | 1707 |
|
2017
Q1 | $2.07M | Sell |
391,261
-5,700
| -1% | -$30.2K | ﹤0.01% | 1721 |
|
2016
Q4 | $2.85M | Buy |
396,961
+6,961
| +2% | +$50K | ﹤0.01% | 1662 |
|
2016
Q3 | $3.65M | Hold |
390,000
| – | – | ﹤0.01% | 1567 |
|
2016
Q2 | $2.47M | Sell |
390,000
-10,000
| -3% | -$63.2K | ﹤0.01% | 1625 |
|
2016
Q1 | $2.21M | Hold |
400,000
| – | – | ﹤0.01% | 1607 |
|
2015
Q4 | $2.23M | Buy |
400,000
+127,300
| +47% | +$710K | ﹤0.01% | 1611 |
|
2015
Q3 | $2.31M | Buy |
272,700
+14,200
| +5% | +$120K | ﹤0.01% | 1610 |
|
2015
Q2 | $3.91M | Buy |
258,500
+23,600
| +10% | +$357K | 0.01% | 1513 |
|
2015
Q1 | $3.76M | Hold |
234,900
| – | – | 0.01% | 1489 |
|
2014
Q4 | $4.19M | Sell |
234,900
-10,400
| -4% | -$185K | 0.01% | 1469 |
|
2014
Q3 | $2.46M | Sell |
245,300
-1,200
| -0.5% | -$12K | ﹤0.01% | 1611 |
|
2014
Q2 | $3.85M | Sell |
246,500
-8,000
| -3% | -$125K | 0.01% | 1512 |
|
2014
Q1 | $4.72M | Hold |
254,500
| – | – | 0.01% | 1392 |
|
2013
Q4 | $4.86M | Sell |
254,500
-95,500
| -27% | -$1.82M | 0.01% | 1361 |
|
2013
Q3 | $5.72M | Hold |
350,000
| – | – | 0.01% | 1172 |
|
2013
Q2 | $2.65M | Buy |
+350,000
| New | +$2.65M | 0.01% | 1514 |
|